Anti-phosphoserine and anti-phosphothreonine antibodies modulate autophosphorylation of the insulin receptor but not EGF receptor.
We examined the effect of anti-phosphothreonine and anti-phosphoserine antibodies on insulin receptor autophosphorylation. These antibodies did not affect insulin binding activity of the receptor. These antibodies, however, inhibited insulin-stimulated autophosphorylation of insulin receptor, while did not affect EGF-stimulated autophosphorylation of EGF receptor. The inhibition was reversed by adding large amounts of phosphoserine or phosphothreonine. These data suggest that phosphoserine and phosphothreonine on insulin receptor play an important role in insulin-induced conformational change of the receptor.
Kono
S
S
Department of Medicine, Kyoto University Faculty of Medicine, Japan.
Kuzuya
H
H
Yamada
K
K
Yoshimasa
Y
Y
Okamoto
M
M
Inoue
G
G
Hayashi
T
T
Nakao
K
K
Imura
H
H
D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D002478:Cells, Cultured; D066246:ErbB Receptors / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D010766:Phosphorylation / Q000187:drug effects; D010768:Phosphoserine / Q000276:immunology*; D010769:Phosphothreonine / Q000276:immunology*; D011972:Receptor, Insulin / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*
D000906:Antibodies; D010769:Phosphothreonine; D010768:Phosphoserine; D066246:ErbB Receptors; D011972:Receptor, Insulin